The best unknown biotech in the world. Bar none.
Posted on January 12th, 2009 in Actelion, Biotech, Ceredase, Gaucher Disease, Genzyme, Gilead, Glaxo-SmithKline, Hoffman LaRoche, Hypertension, Merck, PAH, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Swiss Biotech, Tracleer, Uncategorized, Ventavis, Zavesca Actelion, Add new tag, Biotech, Ceredase, Gaucher Disease, Genzyme, Gilead, Glaxo-SmithKline, Hoffman LaRoche, Hypertension, Merck, PAH, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Swiss Biotech, Tracleer, Ventavis, Zavesca
The best biotech stock in the world – unknown to US analysts is a Swiss Biotech with three products and over a billion in revenue. With enviable gross margins, and absolutely no coverage in the US [except for coverage by Bapcha Murty's eponymous stock research firm], this could be an excellent addition to the portfolio of a risk-tolerant investor who is looking for capital appreciation.
More on this topic
(What's this?)
The “Biotech Super Bowl” Starts Tomorrow… Are You Ready?
(Investment U, 6/3/10)
The American Biotech Revolution: How to Invest in The Biotechnology Sector
(Investment U, 5/14/10)
“Bio Seeds — California Biotech Cleared to Bypass FDA – Next Month – for 22,627% Gains”
(Stock Gumshoe, 6/17/10)
Published by Bapcha Murty // Comment now »
